Fosun Pharma to acquire KKR’s stake in Gland Pharma
Shanghai Fosun Pharmaceutical (Fosun Pharma), a Chinese healthcare provider, is to acquire an 86 per cent stake in Indian generic injectable pharmaceutical products company Gland Pharma for up to USD1.26 billion. The deal will see Fosun Pharma purchase all shares of Gland owned by KKR Floorline Investments in addition to
